Learning while implementing: focus of the new JAIDS supplement on implementation research for EMTCT

Cover of JAIDS supplement on implementation research for EMTCT
© 2014 Lippincott Williams & Wilkins

22 October 2014 - A new special supplement of the Journal of Acquired Immune Deficiency Syndromes is dedicated to INSPIRE, a special initiative for implementation research supported by WHO and the Department of Foreign Affairs, Trade and Development of Canada. While the scientific proof for effective interventions to prevent mother-to-child HIV transmission has long been established, there are many barriers seen in countries to fully implement the WHO recommendations. The articles demonstrate how countries have been leading implementation research initiatives to investigate and address major bottlenecks, and to test new approaches to understanding and overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions to prevent and eliminate mother-to-child transmission of HIV.

WHO consultation on PrEP adherence

15 October - WHO organized a small consultation of key experts on the topic of HIV pre-exposure prophylaxis (PrEP) adherence to discuss how to consider and measure PrEP adherence beyond the context of clinical trials. The consultation took place on 8 June 2014 in Miami, USA. The report captures the process of the consultation, key agreements and next action points, and the list of participants.

Scoping consultation on chronic comorbidities in people living with HIV

15 October - WHO organized a consultation with key experts and implementing partners to explore the scope of potential areas to be developed for the upcoming guidelines on the use of antiretrovirals on 8-9 July 2014. A total of 25 participants attended the meeting which was composed of 14 external experts from academic hospitals, national HIV programmes, HIV research institutions and international non-government organisations. In the report you will find the summaries of discussions, agenda and list of participants, links to presentations and documents, and agreed messages and conclusion points by participants.

WHO´s response to HIV/AIDS and viral hepatitis in the European region

Patient receiving hepatitis testing in a mobile clinic
Photo courtesy: UK hepatitis C trust

6 October 2014 – BARCELONA - Gottfried Hirnschall speaks at the HepHIV2014 conference representing the WHO Regional Director for Europe, Zsuzsanna Jakab. In his speech, he highlights the need for increased testing, overall "public health approach" for equitable access, and measurable targets used in HIV response as valuable lessons that should be applied in the response to viral hepatitis. There are estimated 2.2 million people living with HIV and some 28 million adults living with hepatitis B and C in Europe.

Top stories

fact buffet

11.7 million At the end of 2013, 11.7 million people had access to antiretroviral therapy in low- and middle-income countries.

Fact sheet on HIV/AIDS

35 millionAt the end of 2013, 35 million people were living with HIV.

Online Q&A about HIV/AIDS

28 million Over 28 million people are eligible for antiretroviral therapy, under WHO 2013 consolidated ARV guidelines.

10 facts on HIV

Global Health Sector Strategy on HIV/AIDS 2011-2015: Let’s do what’s right for everyone

Global Hepatitis Programme

Contact us

World Health Organization
HIV/AIDS Department
20, Avenue Appia
CH-1211 Geneva 27